USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.
USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.
复制标题
USP5 通过稳定 PD-L1 促进非小细胞肺癌进展
DOI:
10.1038/s41419-021-04356-6
复制
发表时间:
2021-11-05
影响因子:
9
通讯作者:
Chen G
中科院分区:
文献类型:
--
作者:
Pan J;Qiao Y;Chen C;Zang H;Zhang X;Qi F;Chang C;Yang F;Sun M;Lin S;Tang Q;Li L;Wang M;Wu M;Liu Y;Lai C;Chen J;Chen G
PD-L1(CD274) is a well-known immunosuppressive molecule, which confers immunoescape features to cancer cells and has become one of the major targets in cancer immunotherapies. Understanding the regulatory mechanisms that control PD-L1 protein expression is important for guiding immune checkpoint blockade therapy. Here, we showed that ubiquitin specific peptidase 5 (USP5) was a novel PD-L1 deubiquitinase in non-small cell lung cancer (NSCLC) cells. USP5 directly interacted with PD-L1 and deubiquitinated PD-L1, therefore enhances PD-L1 protein stability. Meanwhile, USP5 protein levels were highly elevated and positively correlated to PD-L1 levels in NSCLC tissues, and were closely correlated with poor prognosis of these patients. In addition, knockdown of USP5 retarded tumor growth in the Lewis lung carcinoma mouse model. Thus, we identified that USP5 was a new regulator of PD-L1 and targeting USP5 is a promising strategy for cancer therapy.
登录
查看更多内容
影响因子:
16.6
作者:
Sato H;Niimi A;Yasuhara T;Permata TBM;Hagiwara Y;Isono M;Nuryadi E;Sekine R;Oike T;Kakoti S;Yoshimoto Y;Held KD;Suzuki Y;Kono K;Miyagawa K;Nakano T;Shibata A
通讯作者:
Shibata A
影响因子:
15.9
作者:
Chen, Guo;Magis, Andrew T.;Deng, Xingming
通讯作者:
Deng, Xingming
影响因子:
10.1
作者:
Huang, Xing;Zhang, Qi;Bai, Xueli
通讯作者:
Bai, Xueli
影响因子:
50.3
作者:
Lee, Heng-Huan;Wang, Ying-Nai;Hung, Mien-Chie
通讯作者:
Hung, Mien-Chie
影响因子:
50.3
作者:
Lim SO;Li CW;Xia W;Cha JH;Chan LC;Wu Y;Chang SS;Lin WC;Hsu JM;Hsu YH;Kim T;Chang WC;Hsu JL;Yamaguchi H;Ding Q;Wang Y;Yang Y;Chen CH;Sahin AA;Yu D;Hortobagyi GN;Hung MC
通讯作者:
Hung MC